Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine for rebound pain after total knee arthroplasty
ChiCTR2600127920Phase 4Recruiting
- Sponsor
- Ganzhou People's Hospital
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Ganzhou People's Hospital. Primary endpoints: Incidence of rebound pain and Difference in pain scores before and after regression of block between the two groups. Started Jul 2026; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600127920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127920.